Ru Yao

583 total citations
39 papers, 375 citations indexed

About

Ru Yao is a scholar working on Oncology, Cancer Research and Pathology and Forensic Medicine. According to data from OpenAlex, Ru Yao has authored 39 papers receiving a total of 375 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Oncology, 17 papers in Cancer Research and 15 papers in Pathology and Forensic Medicine. Recurrent topics in Ru Yao's work include Breast Cancer Treatment Studies (14 papers), Breast Lesions and Carcinomas (9 papers) and Cancer Genomics and Diagnostics (7 papers). Ru Yao is often cited by papers focused on Breast Cancer Treatment Studies (14 papers), Breast Lesions and Carcinomas (9 papers) and Cancer Genomics and Diagnostics (7 papers). Ru Yao collaborates with scholars based in China, United States and United Kingdom. Ru Yao's co-authors include Yidong Zhou, B. Zhong, Feng Mao, Changjun Wang, Qiang Sun, Songjie Shen, David A. Duchêne, Charles S. P. Foster, Tianqi Zhu and Simon Y. W. Ho and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Endocrinology.

In The Last Decade

Ru Yao

36 papers receiving 368 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ru Yao China	11	152	136	102	74	49	39	375
Chang Ik Yoon South Korea	13	153 1.0×	232 1.7×	104 1.0×	49 0.7×	68 1.4×	48	532
Andrii I. Rozhok United States	14	215 1.4×	176 1.3×	294 2.9×	28 0.4×	52 1.1×	22	631
R. De Vita Italy	11	126 0.8×	59 0.4×	92 0.9×	52 0.7×	86 1.8×	26	368
David N. Boone United States	12	189 1.2×	203 1.5×	540 5.3×	36 0.5×	43 0.9×	26	753
C. Dittrich Austria	15	75 0.5×	184 1.4×	183 1.8×	32 0.4×	156 3.2×	43	542
Julia R. Pon Canada	7	145 1.0×	87 0.6×	301 3.0×	62 0.8×	29 0.6×	7	471
Michael C. Rotter Germany	10	64 0.4×	83 0.6×	66 0.6×	80 1.1×	45 0.9×	22	315
Xiaowei Guan China	11	111 0.7×	119 0.9×	220 2.2×	20 0.3×	82 1.7×	31	498
Andrew Georgiadis United States	8	264 1.7×	144 1.1×	309 3.0×	87 1.2×	97 2.0×	13	639
É. Tournier France	14	92 0.6×	135 1.0×	262 2.6×	113 1.5×	44 0.9×	60	643

Countries citing papers authored by Ru Yao

Since Specialization

Citations

This map shows the geographic impact of Ru Yao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ru Yao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ru Yao more than expected).

Fields of papers citing papers by Ru Yao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ru Yao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ru Yao. The network helps show where Ru Yao may publish in the future.

Co-authorship network of co-authors of Ru Yao

This figure shows the co-authorship network connecting the top 25 collaborators of Ru Yao. A scholar is included among the top collaborators of Ru Yao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ru Yao. Ru Yao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Li, Shengnan, Yanqiu Gu, Panpan Chen, et al.. (2025). Comprehensive two-dimensional primary hepatic stellate cell (HSC) membrane chromatography-based screening of anti-fibrotic components from Schisandra chinensis (Turcz.) Baill. and mechanistic insights into gomisin N against liver fibrosis. Journal of Ethnopharmacology. 351. 120067–120067.

Xu, Ying, Ru Yao, Zhixin Hao, et al.. (2025). [18F]F-FES PET for diagnosis, staging, and endocrine therapy prediction in ER-positive breast cancer: a systematic review and meta-analysis. EJNMMI Research. 15(1). 17–17. 1 indexed citations

Lei, Fan, Ru Yao, Sanjie Jiang, et al.. (2024). Nicotine-induced transcriptional changes and mitochondrial dysfunction in the ventral tegmental area revealed by single-nucleus transcriptomics. Journal of genetics and genomics. 51(11). 1237–1251. 1 indexed citations

Xu, Ying, Ru Yao, Xingtong Zhou, et al.. (2023). Nomogram prediction of the 70-gene signature (MammaPrint) binary and quartile categorized risk using medical history, imaging features and clinicopathological data among Chinese breast cancer patients. Journal of Translational Medicine. 21(1). 798–798. 1 indexed citations

Lian, Jie, Lu Gao, Ru Yao, Yidong Zhou, & Qiang Sun. (2023). Case Report: A 13-year-old adolescent diagnosed as malignant phyllodes tumor combined with rhabdomyosarcoma differentiation. Frontiers in Oncology. 13. 1233208–1233208. 1 indexed citations

Wang, Yahui, Ru Yao, Lijia Wu, et al.. (2023). Identification of genetic and immune signatures for the recurrence of HER2-positive breast cancer after trastuzumab-based treatment. Breast Cancer Research and Treatment. 199(3). 603–615. 2 indexed citations

Yao, Ru, et al.. (2023). Spirocyclopiperazinium salt compound DXL-A-24 improves visceral sensation and gut microbiota in a rat model of irritable bowel syndrome. Heliyon. 9(6). e16544–e16544. 3 indexed citations

Yao, Ru, et al.. (2023). Optimizing Intelligent E-commerce Logistics Path using Shortest Path Algorithm. Frontiers in Computing and Intelligent Systems. 4(2). 110–113. 1 indexed citations

Pan, Bo, Ying Xu, Yidong Zhou, et al.. (2022). Long-term survival of screen-detected synchronous and metachronous bilateral non-palpable breast cancer among Chinese women: a hospital-based study (2003–2017). Breast Cancer Research and Treatment. 196(2). 409–422. 1 indexed citations

10.

Wang, Changjun, Yidong Zhou, Yan Lin, et al.. (2022). Rationale and design of a phase II trial of pyrotinib in combination with nab-paclitaxel as adjuvant therapy for N0/N1mi, HER2 + early breast cancer (PHAEDRA). BMC Cancer. 22(1). 269–269. 1 indexed citations

11.

Zhang, Hui, Rui Xu, Jie Liu, et al.. (2021). G protein-coupled estrogen receptor signaling dependent epidermal growth-like factor expression is required for NPR2 inhibition and meiotic resumption in goat oocytes. Theriogenology. 176. 35–42. 6 indexed citations

12.

Zhou, Yidong, Yaping Xu, Changjun Wang, et al.. (2021). Serial circulating tumor DNA identification associated with the efficacy and prognosis of neoadjuvant chemotherapy in breast cancer. Breast Cancer Research and Treatment. 188(3). 661–673. 10 indexed citations

13.

Zhang, Yanna, et al.. (2020). Ki‐67 index, progesterone receptor expression, histologic grade and tumor size in predicting breast cancer recurrence risk: A consecutive cohort study. Cancer Communications. 40(4). 181–193. 24 indexed citations

14.

Wang, Changjun, Yan Lin, Yidong Zhou, et al.. (2020). Pyrotinib with trastuzumab and aromatase inhibitors as first-line treatment for HER2 positive and hormone receptor positive metastatic or locally advanced breast cancer: study protocol of a randomized controlled trial. BMC Cancer. 20(1). 653–653. 9 indexed citations

15.

Zhou, Yidong, Yaping Xu, Yuhua Gong, et al.. (2019). Clinical factors associated with circulating tumor DNA (ctDNA) in primary breast cancer. Molecular Oncology. 13(5). 1033–1046. 36 indexed citations

16.

Xu, Ying, Bo Pan, Yidong Zhou, et al.. (2018). Mammography-detected ultrasound-negative asymptomatic micro-calcifications in Chinese women: Would it be safe to watch and wait?. Medical Hypotheses. 118. 9–12. 1 indexed citations

17.

Mao, Feng, Ru Yao, Peng Li, et al.. (2017). Predictive clinicopathological characteristics affecting sentinel lymph node metastasis in early breast cancer patients. Translational Cancer Research. 6(5). 968–975. 2 indexed citations

18.

Xia, Zenan, et al.. (2016). Laparoscopic assisted low anterior resection for advanced rectal cancer in a kidney transplant recipient. Medicine. 95(44). e5198–e5198. 1 indexed citations

19.

Wang, Xuefei, Qiang Sun, Qiaofei Liu, et al.. (2016). CTC immune escape mediated by PD-L1. Medical Hypotheses. 93. 138–139. 37 indexed citations

20.

Pan, Bo, Ru Yao, Jie Shi, et al.. (2016). Prognosis of subtypes of the mucinous breast carcinoma in Chinese women: a population-based study of 32-year experience (1983-2014). Oncotarget. 7(25). 38864–38875. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact